Sun Pharma to acquire Odomzo from Novartis
Odomzo has marketing approval in over 30 countries globally including US, Europe and Australia
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
MoHFW, NCC-PvPI to launch Pv training programme
First course from Jan 16-25, last date to apply extended to December 30
Sun Pharma completes acquisition of JSC Biosintez
Russia-based Biosintez focuses on the hospital segment with annual revenues of about $52 million for 2015
US FDA grants accelerated approval to Rubraca
Rubraca is a poly ADP-ribose polymerase (PARP) inhibitor to treat women with a certain type of ovarian cancer
Withdraw nod for 28 drug applications of Ranbaxy: Sun Pharma
In April 2014, Sun Pharma had announced the acquisition of the troubled rival Ranbaxy in an all-stock transaction worth $4 billion
Cipla receives final approval for Generic Tricor tabs
Fenofibrate tabs will be available for commercial shipment in the US in the coming weeks
Lupin launches generic Vfend tabs and Vfend oral suspension in the US
Vfend tablets, 50mg and 200mg had US sales of $81 million while Vfend oral suspension, 40 mg/mL had US sales of $15.2 million
Vivek Vasudev Kamath appointed as MD of MSD in India
Kamath has over 25 years of experience across India, South Asia and ASEAN markets
Domestic sales to drive demand in next three to five years: UBM India survey
The main risk factor recognised by the international respondents is the over-dependence on Chinese sourced APIs, particularly in…
Baxter to buy Claris Lifesciences’ global generic injectables business
The $ 625 mn deal is a move to boost Baxter’s presence in this space
Sun Pharma completes acquisition of Ocular Technologies Sarl
In October this year, Sun Pharma announced acquisition for a front payment of $40 million
Cipla’s Netherlands arm to form JV with Iranian distributor Ahran Tejarat Company
The 16.8 m euro JV proposes to undertake manufacturing and marketing of pharmaceutical products in Iran
Drug companies bet on global M&As in growth pursuit: Moody’s
The report also mentioned that M&As can also enhance the expertise of Indian pharma companies in sophisticated and high-entry…
Lupin receives US FDA approval for generic Topicort ointment
The ointment is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses
AstraZeneca wins Corporate CSR Best Practices Award at NHRD National Conference
Is also a finalist in the HR Best Practices category for its focus on gender diversity
Sun Pharma, Moebius Medical in global licensing deal
To develop novel liposomal non-opiod pain product for osteoarthritis
Natco Pharma launches Tamiflu generic capsules in US
The company's capsules are generic versions of Roches Tamiflu drug
Strides Shasun to acquire Perrigo’s US FDA approved API facility in India
Strides Shasun will acquire 100 per cent of the issued capital of Perrigo API India for a consideration of Rs 1000 million
Prima Nature Care launches sea buckthorn-based phyto-medicines in India
The clinical trials of phyto-medicine have shown remarkable improvements in the conditions of patients with various diseases like…
Biocon features in Asia IP Elite 2016 list
Biocon has built its credibility as an innovation-led enterprise through a track record of IP value creation in discovery,…